Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, and Inflammatory Myopathies and Dermatomyositis.
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease
Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis
Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis
Additional file 7 of Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Additional file 6 of Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the <scp>Canadian Registry</scp> for <scp>Pulmonary Fibrosis</scp>
Lung function trajectory in progressive fibrosing interstitial lung disease
Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis
Detection and Early Referral of Patients With Interstitial Lung Abnormalities
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus